At2g29290 Antibody

What is AT2G29290 and why is it significant in plant molecular research?

AT2G29290 encodes a NAD(P)-binding Rossmann-fold protein family gene (NRG) in Arabidopsis thaliana that has been identified as exhibiting drastically altered alternative splicing (AS) patterns under various conditions . This gene has emerged as an important model for studying RNA processing regulation, particularly in the context of long non-coding RNA (lncRNA) interactions. Research has revealed that AT2G29290's splicing is significantly affected in plants with altered expression of ASCO, a regulatory lncRNA that modulates transcriptome function . The protein appears to function within networks responding to both developmental and stress signaling pathways, making antibodies against this protein valuable tools for investigating fundamental plant molecular mechanisms.

What experimental validation should be performed before using an AT2G29290 antibody?

Before using an AT2G29290 antibody in experimental applications, researchers should perform rigorous validation following established criteria for antibody specificity . This validation should include:

• Verification that the precise antigen sequence used to generate the antibody is known and documented

• Confirmation that western blots show immunoreactive bands of appropriate molecular weight in tissues expressing AT2G29290

• Testing the antibody in tissues from AT2G29290 knockout or knockdown plants as negative controls

• Correlating antibody immunoreactivity with AT2G29290 mRNA expression levels

• Cross-validation using multiple antibodies raised against different epitopes of AT2G29290, which should show similar patterns of immunoreactivity

The experience with commercially available antibodies for other targets demonstrates that inadequately validated antibodies can lead to misleading results and wasted research efforts .

How does AT2G29290 relate to plant stress response pathways?

AT2G29290's alternative splicing patterns are significantly altered in plants with modified expression of the lncRNA ASCO, which has been implicated in plant immune responses . Transcriptomic analysis of ASCO-silenced plants revealed upregulation of multiple immune response genes and enhanced sensitivity to flagellin 22 (flg22), a bacterial elicitor . Several transcription factors involved in pathogen responses, including STZ/ZAT10, MYB29, WRKY33, ERF6, ERF104, and ERF105, show altered expression in these plants . This suggests that AT2G29290, as a target of ASCO-mediated splicing regulation, may function within networks that coordinate plant immune responses. Antibodies targeting AT2G29290 could help elucidate its role in these pathways by enabling protein-level studies across different stress conditions.

What are the best approaches for investigating AT2G29290's alternative splicing patterns at the protein level?

Investigating AT2G29290's alternatively spliced isoforms at the protein level requires combining multiple techniques:

• Isoform-specific antibody development: Design antibodies targeting unique peptide sequences present in specific splice variants

• Mass spectrometry validation: Confirm the presence of splice-junction-spanning peptides to verify the translation of predicted splice variants

• Size discrimination approaches: Use high-resolution gel systems or capillary electrophoresis to separate closely related protein isoforms before western blotting

• Immunoprecipitation followed by RNA analysis: Use validated AT2G29290 antibodies to pull down associated RNAs to identify transcripts being actively translated

The search results indicate that AT2G29290 exhibits drastically altered AS upon ASCO manipulation . This makes it a valuable model for studying how alternative splicing affects protein function across different environmental conditions. Careful antibody selection and validation are crucial when distinguishing between potentially subtle differences in protein isoforms.

How can researchers effectively study interactions between AT2G29290 and the ASCO lncRNA regulatory complex?

Studying interactions between AT2G29290 and the ASCO lncRNA regulatory complex requires specialized approaches:

• RNA immunoprecipitation (RIP): Use validated AT2G29290 antibodies to immunoprecipitate the protein along with any directly or indirectly associated RNAs, followed by RT-qPCR or sequencing to detect ASCO

• Cross-linking immunoprecipitation (CLIP): Employ UV crosslinking to stabilize RNA-protein interactions before immunoprecipitation with AT2G29290 antibodies

• Proximity ligation assays: Utilize antibodies against both AT2G29290 and Nuclear Speckle RNA-binding proteins (NSRs), known to interact with ASCO , to detect their close association in situ

• Co-immunoprecipitation studies: Investigate protein complexes containing AT2G29290 and RNA-binding proteins known to interact with ASCO

Research has established that ASCO interacts with NSR proteins to regulate alternative splicing of various genes, including AT2G29290 . Understanding the molecular mechanisms underlying this regulation requires investigating both direct and indirect interactions between AT2G29290 and the ASCO-NSR complex.

What techniques can best identify post-translational modifications (PTMs) of AT2G29290 using antibody-based approaches?

Identifying PTMs of AT2G29290 requires specialized antibody-based techniques:

• PTM-specific antibody screening: Test antibodies against common PTMs (phosphorylation, acetylation, methylation) following AT2G29290 immunoprecipitation

• Peptide array validation: Employ arrays of modified and unmodified peptides from AT2G29290 to validate antibody specificity for particular modifications

• Competitive ELISA approach: Use this technique to determine if antibody binding to AT2G29290 is blocked by specific modified peptides but not by unmodified versions

• PTM enrichment followed by detection: Enrich for specific modifications (e.g., phosphoproteins) from plant extracts, then probe for AT2G29290

• 2D electrophoresis with western blotting: Separate protein isoforms based on charge (affected by PTMs) and size before detection with AT2G29290 antibodies

The search results highlight the importance of rigorous validation approaches for PTM-specific antibodies, including peptide arrays and competitive ELISAs to ensure specificity . These principles should guide investigations of AT2G29290 modifications.

What are the optimal tissue preparation methods for immunolocalization of AT2G29290 in plant tissues?

Optimal tissue preparation for AT2G29290 immunolocalization requires careful consideration of multiple factors:

• Fixation protocols:

  • Use 4% paraformaldehyde for good preservation of protein epitopes

  • Optimize fixation duration (typically 2-4 hours) to preserve tissue architecture while maintaining antigen accessibility

  • Test aldehyde-based vs. alcohol-based fixatives to determine optimal epitope preservation

• Embedding and sectioning:

  • Compare paraffin embedding (better morphology) vs. cryosectioning (better antigen preservation)

  • Optimize section thickness (typically 5-10 μm) for adequate signal without excessive background

  • Consider vibratome sectioning for delicate tissues to minimize processing artifacts

• Antigen retrieval:

  • Test heat-induced epitope retrieval using citrate buffer (pH 6.0) or Tris-EDTA buffer (pH 9.0)

  • Evaluate enzymatic retrieval methods (proteinase K, trypsin) at different concentrations

  • Optimize retrieval duration to maximize signal while preserving tissue integrity

• Controls and validation:

  • Include AT2G29290 knockout/knockdown tissues as negative controls

  • Perform peptide competition assays to verify antibody specificity

  • Compare localization patterns using different antibodies targeting different AT2G29290 epitopes

The principles of immunohistochemical validation outlined in the search results emphasize the importance of complementary validation approaches to ensure reliable localization results.

What troubleshooting strategies should be employed when AT2G29290 antibodies yield inconsistent western blot results?

When facing inconsistent western blot results with AT2G29290 antibodies, systematically address potential issues:

• Antibody validation concerns:

  • Test the antibody on tissues from AT2G29290 knockout/knockdown plants to confirm specificity

  • Evaluate multiple antibodies targeting different epitopes of AT2G29290

  • Perform dot blot or ELISA tests to assess antibody binding capacity under non-denaturing conditions

• Sample preparation optimization:

  • Test different extraction buffers to improve solubilization (adjust detergent type/concentration)

  • Add protease inhibitor cocktails to prevent degradation during extraction

  • Compare fresh vs. frozen tissue extraction efficiency

  • Optimize protein loading amount (create a dilution series)

• Protocol modification:

  • Adjust transfer conditions (time, voltage, buffer composition) for different membrane types

  • Test different blocking agents (milk vs. BSA) and concentrations

  • Optimize primary antibody concentration and incubation conditions

  • Evaluate alternative detection systems (ECL vs. fluorescent)

• Technical validation:

  • Include positive controls (if available) and appropriate loading controls

  • Verify transfer efficiency using Ponceau S or total protein stains

  • Ensure consistent SDS-PAGE separation by checking gel percentage and running conditions

The search results highlight how even commercially available antibodies can yield inconsistent and non-specific results , underscoring the importance of rigorous validation and troubleshooting approaches.

How can researchers quantitatively analyze AT2G29290 expression across different experimental conditions?

Quantitative analysis of AT2G29290 expression requires rigorous experimental design and appropriate analytical methods:

• Western blot quantification:

  • Design experiments with at least 3-4 biological replicates

  • Include internal loading controls (constitutively expressed proteins)

  • Create standard curves using purified protein or serial dilutions

  • Use image analysis software with background subtraction capabilities

  • Apply appropriate statistical tests to determine significance of changes

• Immunohistochemistry quantification:

  • Establish consistent imaging parameters (exposure, gain, offset)

  • Analyze multiple fields per sample (10-20 minimum)

  • Use automated image analysis for unbiased quantification

  • Apply appropriate normalization to control for section thickness variations

  • Correlate protein localization with mRNA expression data

• Flow cytometry (for protoplasts):

  • Optimize protoplast isolation to maintain protein epitopes

  • Establish proper gating strategies to exclude debris and aggregates

  • Include fluorescence minus one (FMO) controls

  • Use median fluorescence intensity (MFI) for quantitative comparisons

  • Correlate with western blot results for validation

• ELISA-based quantification:

  • Develop sandwich ELISA using two antibodies recognizing different epitopes

  • Create standard curves using recombinant protein if available

  • Analyze samples in triplicate with appropriate dilution series

  • Include spike-in controls to assess matrix effects

The search results emphasize the importance of combining multiple analytical approaches for robust quantification and the need for appropriate controls to ensure specificity .

What strategies can differentiate between closely related protein family members when using AT2G29290 antibodies?

Differentiating AT2G29290 from closely related NAD(P)-binding Rossmann-fold proteins requires specialized strategies:

• Epitope selection and antibody design:

  • Target unique regions that differ among family members

  • Avoid conserved domains such as the NAD(P)-binding motif

  • Consider using synthetic peptides for immunization that represent unique regions

  • Test antibody cross-reactivity against recombinant proteins of related family members

• Validation with genetic resources:

  • Test antibodies on tissues from knockout/knockdown plants for AT2G29290

  • Compare immunoreactivity patterns in plants overexpressing AT2G29290

  • Create experimental samples with differential expression of related family members

• Analysis techniques:

  • Use high-resolution gel systems to separate closely related proteins by size

  • Employ 2D electrophoresis to separate proteins by both pI and molecular weight

  • Perform immunoprecipitation followed by mass spectrometry to confirm identity

  • Consider using peptide competition assays with peptides from related family members

• Data interpretation:

  • Create a table of expected molecular weights and expression patterns for family members

  • Correlate protein detection with mRNA expression data from RT-qPCR or RNA-seq

  • Compare observed patterns with predicted subcellular localization of family members

The search results emphasize that antibodies often exhibit unexpected cross-reactivity and that comprehensive validation using genetic resources is essential for ensuring specificity .